EXAS vs MEG · rev $2.76B vs rev $696.4M
EXACT Sciences Corporation (EXAS) versus Montrose Environmental Grp (MEG) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Montrose Environmental Grp (MEG) is a waste management company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MEG revenue for 2024-12-31 was $696.4M. Net income was -$62.3M. Revenue was up 11.6% from 2023-12-31 to 2024-12-31. MEG currently screens at market cap $800.8M.
EXAS currently screens at market cap $20.03B. MEG currently screens at market cap $800.8M.
Not investment advice. Open the EXAS and MEG stock pages for the full models.
Not investment advice.